Norwegian version of this page

Type 2 diabetes and metabolism

Our main focus area of research are causes, development and complications of type 2 diabetes.

About the group

We do clinical and mechanistic studies in obesity, prediabetes and diabetes and participate in large epidemiological register-based studies.

We design and conduct our own studies, perform translational research with collaborating laboratories and participate in multi-centre studies initiated from academic collaborators or sponsored by the pharmaceutical industry.

Our aim is to improve prevention and treatment for type 2 diabetes.

Projects

  • STORK Groruddalen
  • MYOGLU
  • DIASA
  • DAPHNE og CVD-REAL
  • FIBERDIA
  • sObR studies
  • Epidemology of Type 2 diabetes in Norway
  • Clinical trials

Collaborators

  • Research Institute for Internal Medicine, OUH, Bente E. Halvorsen
  • Department of Nutrition, UiO, Christian Drevon
  • Physical Performance, NIH, Jørgen Jensen
  • Morbid obesity, OUH, Tom Mala og Jon Kristinsson
  • Medical Physics, OUH and UiO, Christian Tronstad and Department of Physics, UiO, Ørjan G. Martinsen
  • Morbid Obesity, SiV and UiO, Jøran Hjelmesæth and Dag Hofsø
  • Section for Pharmacology and Pharmaceutical Biosciences, UiO, Arild Rustan
  • Department of Clinical Molecular Biology (EpiGen), UiO, Yvonne Böttcher
  • Chronic Diseases and Ageing, NIPH
  • Astra Zeneca Nordic.Baltic, Johan Bodegaard
Published Dec. 14, 2021 1:26 PM - Last modified Dec. 14, 2021 1:26 PM

Contact

Gruppeleder

Participants

Detailed list of participants